Often, patients enrolled in clinical trials live longer than those who are not, however, a new study shows that the survival benefit may be due to the patient’s health, not the treatment received in the clinical trial. Patients interested in clinical trials may also be more involved in decision making, which some believe affects outcomes.
Read “Does Enrollment in Cancer Trials Improve Survival” in Journal of the American College of Surgeons.
A research team, led by Dr. Ugo Cavallaro and supported by OCRA’s 2019 Collaborative Research Development Grant, made progress toward improving immunotherapies for ovarian cancer. Dr. Frances R. Balkwill, a … Continued
Leaders in the patient advocacy space came together for a wide-ranging study on the often-overlooked challenges faced by caregivers of cancer patients, with Tracy Moore, LCSW, who serves as Ovarian … Continued
A study published in Nature Cancer details how OCRA-funded research has dramatically expanded the impact of DNA and RNA data in the Cancer Genome Atlas and Cancer Cell Line Encyclopedia, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
